Merck & Co Inc reports results for the quarter ended June 30 - Earnings Summary

• Merck & Co Inc MRK.N reported quarterly adjusted earnings of $2.19​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $2.28. The mean expectation of fourteen analysts for the quarter was for earnings of $2.01 per share. Wall Street expected results to range from $1.88 to $2.07 per share.

• Revenue fell 1.9% to $15.81 billion from a year ago; analysts expected $15.89 billion.

• Merck & Co Inc's reported EPS for the quarter was $1.76​.

• The company reported quarterly net income of $4.43 billion.

• Merck & Co Inc shares had risen by 6.2% this quarter and lost 15.5% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 1.7% in the last three months.​

• In the last 30 days, seven analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy," 11 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for Merck & Co Inc is $100.00, about 15.9% above its last closing price of $84.06

This summary was machine generated from LSEG data July 29 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)